Clintel Consulting
Expert Clinical Pharmacology & Pharmacometrics Services
Founded by Abrarali Attarwala
Expert Clinical Pharmacology & Pharmacometrics Services
Founded by Abrarali Attarwala
Clintel is a consultancy dedicated to advancing model-informed drug development (MIDD) through expert clinical pharmacology and pharmacometrics strategies. Founded by seasoned Clinical Pharmacologists and Pharmacometricians with over two decade of experience, Clintel bridges the gap between data and decision-making in the pharmaceutical and biotech sectors.
We provide strategic guidance throughout the drug development lifecycle—from early-phase studies to regulatory submissions. Our tailored strategies optimize pharmacological insights for robust and efficient development programs.
We develop population pharmacokinetic/pharmacodynamic (PK/PD) models to support dose selection, quantify variability, and design efficient trials. These models form the backbone of data-driven therapeutic decisions.
Physiologically Based Pharmacokinetic (PBPK) modeling is used to simulate drug behavior in specific populations and predict complex interactions. It enables confident extrapolation to special populations like pediatrics, geriatrics, and those with hepatic or renal impairment.
MIDD integrates data across studies to inform key decisions, minimize trial burden, and accelerate development timelines. We use simulation and modeling tools to reduce uncertainty and improve regulatory success rates.
Email: abrarali@clintel.ai